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Introduction
Healthcare-associated pneumonia is associated with high
mortality rates in critically ill especially those with mul-
tidrug-resistant pathogens.
Objectives
The aim of the present study is to evaluate the value of
C-reactive protein (CRP) ratio in the outcome of ICU
cancer patients with healthcare-associated pneumonia
(HCAP).
Methods
This was a secondary analysis of a prospective cohort of
cancer patients admitted to three ICUs with healthcare-
associated pneumonia. CRP was sampled every other
day from D0 do D6 of antibiotic prescription. CRP-ratio
was calculated in relation to D0 CRP concentration.
Comparison between survivors and non-survivors was
performed.
Results
137 patients were included in the study (median age:
65 years; solid tumors 69%; neutropenia 13%). Good
performance status was observed in 61% of all patients.
The median Charlson comorbidity index was 3 points.
Septic shock at ICU admission was present in 74% of
patients and invasive mechanical ventilation was used in
73% while 27% used dialysis. 30-day and hospital mor-
tality rates were 54% and 65% respectively.
The course of CRP from D0 to D6 as well as CRP-ratio
were significantly different in survivors and non-survivors
(p = 0.017 and p = 0.03, respectively). After 48h of antibiotic
therapy CRP concentration was significantly lower in sur-
vivors (p = 0.042)). By D4, both CPR and CRP-ratio of
survivors were significantly lower (p < 0.001 and p =
0.004, respectively). The AUC of CRP and CRP-ratio by
D4 in the identification of patients with poor outcome
were 0.717 and 0.662, respectively.
Conclusions
The rate of CRP decrease, assessed either by absolute as
well as relative changes, after antibiotic prescription in
cancer patients with HCAP was markedly associated
with mortality and may be used as an early predictor of
outcome.
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